Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts

Affiliations

• ¹ The Florey Institute, The University of Melbourne, Victoria, Australia; Melbourne School of Psychological Science, University of Melbourne, Victoria, Australia; Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: [email protected].
• ² Department of Neurology, Stanford University, CA, USA.
• ³ Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
• ⁴ Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
• ⁵ Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
• ⁶ The Florey Institute, The University of Melbourne, Victoria, Australia.
• ⁷ Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA; Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht University, Maastricht, The Netherlands.
• ⁸ The Australian eHealth Research Centre, CSIRO Health & Biosecurity, Victoria, Australia.
• ⁹ Harvard Aging Brain Study, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Cliniques Universitaires Saint-Luc, Institute of Neuroscience, Université Catholique de Louvain, Brussels, Belgium.
• ¹⁰ The Australian eHealth Research Centre, CSIRO Health & Biosecurity, Queensland, Australia.
• ¹¹ The University of Queensland, School of Public Health, Faculty of Medicine, Queensland, Australia.
• ¹² Department of Nuclear Medicine and Centre for PET, Austin Health, Victoria, Australia; Department of Medicine, Austin Health, The University of Melbourne, Victoria, Australia.
• ¹³ Cogstate, Ltd., Australia.
• ¹⁴ Department of Neurology, University of Southern California, San Diego, CA, USA.
• ¹⁵ Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.